Taihe Technologies(300801)
Search documents
丙烯酸概念上涨2.64% 5股主力资金净流入超千万元
Zheng Quan Shi Bao Wang· 2026-01-20 09:17
Group 1 - The acrylic acid concept increased by 2.64%, ranking third among concept sectors, with 13 stocks rising, including Hongqiang Co., which hit the daily limit, and Bohai Chemical, Taihe Technology, and Satellite Chemical, which rose by 7.56%, 6.71%, and 6.67% respectively [1] - The acrylic acid sector saw a net inflow of 329 million yuan from main funds, with 10 stocks receiving net inflows, and 5 stocks exceeding 10 million yuan in net inflow, led by Wanhua Chemical with a net inflow of 174 million yuan [2] - The top stocks by net inflow ratio included Hongqiang Co., ST Shenhua, and Daoshengtian, with net inflow ratios of 42.22%, 11.79%, and 5.01% respectively [3] Group 2 - The top performers in the acrylic acid sector included Wanhua Chemical with a 4.39% increase, Tianlong Group with a 6.04% increase, and Hongqiang Co. with a 10.00% increase [3] - The stocks with the largest declines included Guoen Co. with a decrease of 2.04%, Brother Technology with a decrease of 0.87%, and Akoli with a decrease of 0.61% [4] - The trading volume and turnover rates varied, with Hongqiang Co. having a turnover rate of 10.78% and Tianlong Group at 26.90% [3][4]
泰和科技:泰和科技研发的脑波生物反馈装置并非公司主营业务
Zheng Quan Ri Bao Wang· 2026-01-16 09:52
Core Viewpoint - Taihe Technology (300801) clarified that its brainwave biofeedback device is not part of the company's main business and is currently not on the market, being in the performance and appearance optimization stage, which does not significantly impact the company's operating performance [1] Summary by Relevant Categories - **Product Development** - The brainwave biofeedback device is still in the optimization phase and has not been launched in the market [1] - **Business Impact** - The project does not have a significant impact on the company's operating performance at this stage [1] - **Investor Communication** - The company encourages investors to pay attention to regular announcements for updates on the project [1]
泰和科技:截至2026年1月9日公司共有股东29361户
Zheng Quan Ri Bao Wang· 2026-01-13 10:12
Group 1 - The core point of the article is that Taihe Technology (300801) has a total of 29,361 shareholders as of January 9, 2026 [1]
泰和科技涨2.03%,成交额2.68亿元,主力资金净流出1317.57万元
Xin Lang Zheng Quan· 2026-01-08 05:10
Group 1 - The core viewpoint of the news is that Taihe Technology has shown significant stock performance and financial growth, with a notable increase in revenue and net profit year-over-year [1][2]. - As of January 8, Taihe Technology's stock price increased by 14.59% year-to-date, with a 12.79% rise over the last five trading days and a 22.00% increase over the last 60 days [1]. - The company reported a revenue of 2.12 billion yuan for the period from January to September 2025, representing a year-on-year growth of 27.73%, and a net profit of 88.77 million yuan, up 5.99% year-on-year [2]. Group 2 - Taihe Technology has a market capitalization of 6.915 billion yuan, with a trading volume of 268 million yuan and a turnover rate of 6.31% as of January 8 [1]. - The company has a diverse revenue structure, with 76.35% of its income coming from water treatment agents and 23.10% from chlor-alkali products [1]. - Since its A-share listing, Taihe Technology has distributed a total of 375 million yuan in dividends, with 174 million yuan distributed over the past three years [3].
泰和科技:脑波生物反馈装置尚未采用深度学习等AI技术
Zheng Quan Ri Bao Zhi Sheng· 2026-01-07 14:09
Group 1 - The core viewpoint of the article is that Taihe Technology's brainwave biofeedback device is currently based on classical algorithms and has not yet adopted deep learning or AI technologies [1] - The technology is still in the internal performance testing and appearance design optimization phase and has not been launched in the market [1]
泰和科技:公司研发的脑波生物反馈装置的性能和外观在持续改进中
Zheng Quan Ri Bao Wang· 2026-01-06 09:11
Core Viewpoint - Taihe Technology (300801) is currently improving the performance and appearance of its brainwave biofeedback device, which has not yet entered mass production and is not accepting orders, indicating a need for caution regarding investment risks [1]. Group 1 - The brainwave biofeedback device developed by Taihe Technology is undergoing continuous improvements [1]. - The device has not yet reached the stage of mass production [1]. - Taihe Technology is currently unable to accept orders for the device [1].
泰和科技:脑波生物反馈装置的性能和外观在持续地改进中,尚未批量生产
Xin Lang Cai Jing· 2026-01-06 03:53
Core Viewpoint - The company is currently improving the performance and appearance of its brainwave biofeedback device, which has not yet entered mass production and is not accepting orders [1] Group 1 - The brainwave biofeedback device is under continuous development [1] - The company has not started mass production of the device [1] - Orders for the device are not being accepted at this time [1]
泰和科技:公司研发的脑波生物反馈装置的性能和外观在持续地改进中,尚未批量生产,还不能接受订单
Mei Ri Jing Ji Xin Wen· 2026-01-06 03:46
Core Viewpoint - The company, Taihe Technology, has indicated that its brainwave biofeedback devices are still in the process of performance and appearance improvements and are not yet in mass production, thus unable to accept orders [1] Group 1 - The brainwave biofeedback device is under continuous development for performance and design enhancements [1] - The company has not yet commenced mass production of the brainwave biofeedback device [1] - There are currently no orders being accepted for the brainwave biofeedback device [1]
泰和科技跌2.04%,成交额1.29亿元,主力资金净流出239.90万元
Xin Lang Cai Jing· 2026-01-06 01:57
Group 1 - The core viewpoint of the news is that Taihe Technology's stock has experienced fluctuations, with a recent decline of 2.04% and a total market value of 6.828 billion yuan [1] - As of January 6, Taihe Technology's stock price is 31.26 yuan per share, with a trading volume of 1.29 billion yuan and a turnover rate of 3.00% [1] - The company has seen a year-to-date stock price increase of 13.14%, with significant gains over the past 5 days (10.46%), 20 days (11.72%), and 60 days (20.23%) [1] Group 2 - Taihe Technology's main business involves the research, production, and sales of water treatment agents, contributing 76.35% to its revenue, while chlor-alkali products account for 23.10% [1] - As of December 31, the number of shareholders has increased to 25,400, a rise of 7.12%, while the average circulating shares per person decreased by 6.65% to 5,389 shares [2] - For the period from January to September 2025, Taihe Technology achieved operating revenue of 2.119 billion yuan, representing a year-on-year growth of 27.73%, and a net profit attributable to shareholders of 88.7656 million yuan, up 5.99% year-on-year [2]
泰和科技:截至2025年12月31日公司共有股东25397户
Zheng Quan Ri Bao Wang· 2026-01-05 14:12
Group 1 - The core point of the article is that Taihe Technology (300801) has disclosed its shareholder information, indicating a total of 25,397 shareholders as of December 31, 2025 [1]